|
Volumn 21, Issue 6 A, 2001, Pages 3777-3784
|
WP744, a novel anthracycline with enhanced proapoptotic and antileukemic activity
a a a a a a a a a a |
Author keywords
AML; Anthracyclines; Apoptosis; Drug resistance; MDR1; MRP1
|
Indexed keywords
ANTHRACYCLINE DERIVATIVE;
DAUNORUBICIN;
DOXORUBICIN;
NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE;
UNCLASSIFIED DRUG;
WP 744;
ACUTE GRANULOCYTIC LEUKEMIA;
ACUTE LYMPHOBLASTIC LEUKEMIA;
ANTINEOPLASTIC ACTIVITY;
APOPTOSIS;
ARTICLE;
CANCER CELL CULTURE;
CANCER INHIBITION;
CONTROLLED STUDY;
DRUG ACTIVITY;
DRUG FORMULATION;
DRUG MECHANISM;
DRUG POTENCY;
DRUG STRUCTURE;
HUMAN;
HUMAN CELL;
IC 50;
PRIORITY JOURNAL;
ADULT;
AGED;
ANTHRACYCLINES;
ANTIBIOTICS, ANTINEOPLASTIC;
APOPTOSIS;
CASPASE 3;
CASPASES;
CELL DIVISION;
DNA FRAGMENTATION;
DOXORUBICIN;
FEMALE;
GROWTH INHIBITORS;
HUMANS;
K562 CELLS;
LEUKEMIA, MONOCYTIC, ACUTE;
LEUKEMIA, MYELOCYTIC, ACUTE;
MALE;
MIDDLE AGED;
POLY(ADP-RIBOSE) POLYMERASES;
TUMOR CELLS, CULTURED;
|
EID: 0035570755
PISSN: 02507005
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (12)
|
References (27)
|